Publications by authors named "Wen-Hong Lin"

Claim this Profile
M
Multi-wavelength and central-wavelength-tunable solitons and soliton molecules in a SMF-GIMF-SMF mode-locked fiber laser.
Ting Xu, Lie Liu, Bing Wu, Qiong Wu, Hong-Lin Wen

Opt Express· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors.
Matthew H Taylor, Aung Naing, John Powderly, Paul Woodard, Luke Chung, Wen Hong Lin

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease.
Wen-Hong Lin, Fei Tang, Sheng-Sheng Liu

Am J Transl Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China.
Wen-Hong Lin, Chao Yao, Lin Mei, Dong-Ping Wang, Xun-Di Bao

Am J Transl Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tunable and switchable multi-wavelength mode-locked fiber lasers induced by an optimized hybrid mode-locked composite filtering effect.
Ying Han, Lie Liu, Qi Li, Ying-Ying Li, Hong-Lin Wen

Opt Express· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer.
Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, Maria Ochoa-de-Olza, Sandip Pravin Patel, Ivelina Gueorguieva, Wen Hong Lin

BMC Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creeping and erupting dynamics in a pure-quartic soliton fiber laser.
Ying Han, Bo Gao, Ge Wu, Jia-Yu Huo, Hong-Lin Wen

Opt Express· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials.
Yoon-Koo Kang, Martin Reck, Paul Nghiem, Yan Feng, Gregory Plautz, Wen Hong Lin

J Immunother Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of ficolin-1 and ficolin-3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population.
Ye Li, En-Qing You, Wen-Hong Lin, Xiao-Ning Liu, De-Pei Shen

J Clin Lab Anal· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.
Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck, Wen Hong Lin

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort.
Neal E Ready, Patrick A Ott, Matthew D Hellmann, Jon Zugazagoitia, Christine L Hann, Wen Hong Lin

J Thorac Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370).
David R Spigel, Craig Reynolds, David Waterhouse, Edward B Garon, Jason Chandler, Wen Hong Lin

J Thorac Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers.
Pieter-Jan de Kam, Jie Hou, Zaiqi Wang, Wen Hong Lin, Michiel van den Heuvel

Int J Clin Pharmacol Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing second renal allograft survival: a single center experience in China.
Dong Wang, Ting-Zhao Xu, Jin-Hua Chen, Wei-Zhen Wu, Shun-Liang Yang, Wen-Hong Lin

Transpl Immunol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Shun-liang Yang, Dong Wang, Wei-zhen Wu, Wen-hong Lin, Ting-zhao Xu

Transpl Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
Dong Wang, Guo-Jun Wu, Wei-Zhen Wu, Shun-Liang Yang, Jin-Hua Chen, Wen-Hong Lin

Transpl Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Biologic activity of bispecific single chain antibody against human gamma-seminoprotein and CD3 molecule].
Dong Wang, He Wang, Guo-jun Wu, Wei-zhen Wu, Shun-liang Yang, Wen-hong Lin

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
Artur Filipecki, Sanjeev Saksena, Wen Hong Lin

Am J Cardiol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Significance of detecting urinary monocyte chemotactic peptide-1 in renal transplant recipient].
Xing-hui Sun, Jian-ming Tan, Wei-zhen Wu, Wen-hong Lin, Qian-sheng Li

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis